MedTrace Logo

Etiology of Lymphopenia in Covid19 Infection

NCT04404608 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 172

Last updated 2022-07-20

No results posted yet for this study

Summary

Study of the cause of lymphopenia in Covid19 viral infection will be done in 3 cohorts. First cohort will be patients asymptomatic or with mild symptoms. Second cohort will be patients with severe illness and admitted to ICU. Third cohort will be patients critically ill and on artificial ventilation.

Conditions

Interventions

DIAGNOSTIC_TEST

Complete blood picture, bone marrow aspiration cytology

none except the regular routine investigations in such cases

Sponsors & Collaborators

  • Dr Medhat Khafagy

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2021-06-01
Completion
2021-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04404608 on ClinicalTrials.gov